Summary
We used ciprofloxacin, a quinolone-derivative, to treat a lung infection due toPseudomonas aeruginosa in an adult cystic fibrosis patient. On three different occasions the use of ciprofloxacin was associated with the development of an asymptomatic hematuria with red blood cell casts. The mechanism responsible for this hematuria is presently unknown, but clinicians should be aware of this potential adverse effect of ciprofloxacin.
Zusammenfassung
Wir behandelten einen erwachsenen Patienten mit zystischer Fibrose wegen seiner durchPseudomonas aeruginosa verursachten Lungeninfektion mit Ciprofloxacin, einem Quinolonderivat. Die Einnahme von Ciprofloxacin war wiederholt mit dem Auftreten einer asymptomatischen Hämaturie verbunden. Obwohl der dafür verantwortliche pathogenetische Mechanismus zur Zeit unbekannt ist, sollte auf diese mögliche Nebenwirkung von Ciprofloxacin geachtet werden.
Similar content being viewed by others
Literature
Muytjens, H. L., van der Ros-van de Repe, J., van Veldhiuen, G. Comparative activities of ciprofloxacin (Bay O 9867), norfloxacin, pipemidic acid, and nalidixic acid. Antimicrob. Agents Chemother. 24 (1983) 302–304.
Höffler, D., Dalhoff, A., Gau, W., Beermann, D., Michl., A. Dose and sex-independent disposition of ciprofloxacin. Eur. J. Clin. Microbiol. 3 (1984) 363–366.
Joos, B., Ledergerber, B., Flepp, M., Bettex, J.-D., Lüthy, R., Siegenthaler, W. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrob. Agents Chemother. 27 (1985) 353–356.
Appel, G. B., Neu, H. C. The nephrotoxicity of antimicrobial agents. N. Engl. J. Med. 296 (1977) 784–787.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garlando, F., Täuber, M.G., Joos, B. et al. Ciprofloxacin-induced hematuria. Infection 13, 177–178 (1985). https://doi.org/10.1007/BF01642807
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01642807